Learn more about Novartis in Neuroscience
Additional resources
At this year’s European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Annual Meeting, we will be sharing the latest data and research from our neuroscience portfolio, driven by our commitment to collaborate on industry-leading treatments in multiple sclerosis, neuroimmunology, neurodegeneration and neuromuscular/rare diseases.
Additional resources